Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SGX:T14 Stock Report

Market Cap: US$3.0b

Tianjin Pharmaceutical Da Ren Tang Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Lei Wang

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure2.4yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?

Nov 03
Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?

Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 08
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value

Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?

Jul 21
Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?

We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease

Jun 20
We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease

If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity

Apr 17
If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity

Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

Mar 01
Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet

Feb 03
Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet

CEO

Lei Wang (53 yo)

2.3yrs

Tenure

CN¥2,625,100

Compensation

Ms. Lei Wang serves as Executive Director of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited since December 30, 2022 and serves as its General Manager since August 22, 2022. She served as Gene...


Leadership Team

NamePositionTenureCompensationOwnership
Lei Wang
GM & Executive Director2.3yrsCN¥2.63mno data
Jian Ma
Chief Financial Officer1.3yrsCN¥190.30kno data
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
$ 91.8k
Min Guo
Executive Directorno datano datano data
Yu Zhang
Chief Manufacturing Officer2.6yrsCN¥893.80kno data
Mingjie Shang
Executive Directorless than a yearCN¥299.00kno data
Yan Jiao
Secretary to the Board of Directors16.9yrsCN¥445.80k0.0013%
$ 39.2k

2.4yrs

Average Tenure

53yo

Average Age

Experienced Management: T14's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lei Wang
GM & Executive Director1.9yrsCN¥2.63mno data
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
$ 91.8k
Min Guo
Executive Director3.3yrsno datano data
Mingjie Shang
Executive Director1.4yrsCN¥299.00kno data
Yoke Pheng Liew
Independent & Non-Executive Director4.4yrsCN¥259.16kno data
Yuanxia Wang
Chairman of Board of Supervisors4.9yrsno datano data
Jianhua Xing
Supervisor2.9yrsno datano data
Mingrui Zhang
Non-Executive & Non-Independent Chairman2.9yrsno datano data
Weiwen Mao
Non-Executive Non-Independent Director1.9yrsno datano data
Guat Kwang Yeo
Lead Independent Directorless than a yearno datano data
Ming Zhong
Independent Directorless than a yearno datano data

2.9yrs

Average Tenure

53yo

Average Age

Experienced Board: T14's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.